BioNTech
VerifiedDevelops personalized immunotherapies with a focus on cancer medicine.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$4.8b (Public information from May 2024)
Share price
$90.88 BNTX
Company register number HRB 48720 (Mainz)
Mainz Rhineland-Palatinate (HQ)